Explore all of ul.com

The US Food and Drug Administration has drafted a guidance document on gluten labeling in drug products.

This draft guidance intends to convey to drug manufacturers FDA’s recommendations on how certain oral drug products should be labeled regarding gluten, a matter of interest to individuals with celiac disease.

The draft is open for comments until February 12, 2018.

SOURCE

Share